secwatch.observer — SEC 8-K summary
======================================

Issuer:     20/20 Biolabs, Inc. (AIDX)
CIK:        0001139685
Form:       8-K
Filed at:   2026-05-26T20:28:45+00:00
Accession:  0001213900-26-061039
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

20/20 Biolabs reduces stockholder meeting quorum from majority to one-third
---------------------------------------------------------------------------

- Board adopted Amendment No. 1 to Bylaws on May 19, 2026.
- Quorum required for stockholder meetings reduced from majority to one-third of outstanding shares.
- Amendment to Section 2.5 of Amended and Restated Bylaws; effective immediately.
- No other changes to stockholder rights or company governance structure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1139685/000121390026061039/0001213900-26-061039-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1139685/000121390026061039/ea0292180-8k_2020bio.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-061039

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer